RENAU.UNSP.ARD 1/5 EO-20 - Asset Resilience Ratio
RENAU.UNSP.ARD 1/5 EO-20 (56S0) has an Asset Resilience Ratio of 0.32% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 56S0 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how RENAU.UNSP.ARD 1/5 EO-20's Asset Resilience Ratio has changed over time. See debt-free asset ratio of RENAU.UNSP.ARD 1/5 EO-20 to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down RENAU.UNSP.ARD 1/5 EO-20's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see RENAU.UNSP.ARD 1/5 EO-20 (56S0) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €26.20 Million | 0.32% |
| Total Liquid Assets | €26.20 Million | 0.32% |
Asset Resilience Insights
- Limited Liquidity: RENAU.UNSP.ARD 1/5 EO-20 maintains only 0.32% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
RENAU.UNSP.ARD 1/5 EO-20 Industry Peers by Asset Resilience Ratio
Compare RENAU.UNSP.ARD 1/5 EO-20's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
QITIAN Technology Group Co Ltd
SHE:300061 |
Medical Instruments & Supplies | 0.00% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.29% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
Annual Asset Resilience Ratio for RENAU.UNSP.ARD 1/5 EO-20 (2022–2025)
The table below shows the annual Asset Resilience Ratio data for RENAU.UNSP.ARD 1/5 EO-20.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.10% | €8.10 Million ≈ $9.47 Million |
€7.98 Billion ≈ $9.33 Billion |
-0.02pp |
| 2024-12-31 | 0.12% | €9.90 Million ≈ $11.57 Million |
€8.26 Billion ≈ $9.65 Billion |
0.00pp |
| 2023-12-31 | 0.12% | €9.50 Million ≈ $11.11 Million |
€7.73 Billion ≈ $9.04 Billion |
-0.39pp |
| 2022-12-31 | 0.51% | €25.90 Million ≈ $30.28 Million |
€5.07 Billion ≈ $5.92 Billion |
-- |
About RENAU.UNSP.ARD 1/5 EO-20
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more